Author(s): Halouska S, Chacon O, Fenton RJ, Zinniel DK, Barletta RG,
Abstract Share this page
Abstract D-Cycloserine (DCS) is only used with multidrug-resistant strains of tuberculosis because of serious side effects. DCS is known to inhibit cell wall biosynthesis, but the in vivo lethal target is still unknown. We have applied NMR-based metabolomics combined with principal component analysis to monitor the in vivo effect of DCS on Mycobacterium smegmatis. Our analysis suggests DCS functions by inhibiting multiple protein targets.
This article was published in J Proteome Res
and referenced in Journal of Computer Science & Systems Biology